期刊文献+

可疑肾实质来源肿瘤患者术前评估^(18)F-FDG PET/CT图像特点分析

Research on FDG PET/CT imaging characteristics of the patients suspicious for renal parenchyma neoplasm before surgery
下载PDF
导出
摘要 目的:分析探讨临床可疑肾实质来源肿瘤患者术前^(18)F-FDG PET/CT影像特点。方法:回顾性选取126例可疑肾实质来源恶性肾肿瘤患者,按照患者的年龄将其分为老年组(42例)和中青年组(84例)。所有患者按常规方法行^(18)F-FDG PET显像,通过勾画感兴趣区(ROI)方法计算原发、转移灶及正常肾实质标准化摄取值最大值(SUVmax)和原发灶靶本比(T/B),以病理结果为金标准进行统计分析。结果:1恶性114例,良性12例,^(18)F-FDG PET诊断敏感度、特异度、阳性和阴性预测值分别为37.72%、83.33%、95.56%和12.35%;2转移患者16例,原发灶大小及SUV均明显高于未转移患者,差异有统计学意义(Z=-4.12,Z=-4.26,P<0.001);3老年患者组原发灶大小、SUV及转移发生率与中青年组相比无显著差异;4透明细胞癌病灶^(18)F-FDG PET阳性率及代谢活性显著低于非透明细胞癌病灶,大小无差异。结论:SUVmax和T/B值均不适用于肾实质来源肿瘤诊断。原发灶代谢明显增高时,诊断恶性把握较大,且病理类型常为非透明细胞癌。肿瘤原发灶越大、代谢越高则越易发生转移。老年肾肿瘤患者的^(18)F-FDG PET影像特点与中青年组一致。 Objective: To conduct retrospective analysis on ^(18F-FDG-PET imaging characteristics of patients suspicious for renal parenchyma neoplasm before surgery. Methods: One hundred and twenty six patients with suspicious for renal parenchyma tumor were enrolled and divided into aged group and middle-age group. All patients underwent routine ^18F-FDG-PET examination. Standard uptake value and T/B ratio were collected by drawing ROI in primary, metastasis lesions and normal renal parenchyma around the primary lesion. Pathological results were taken as golden criterion for further statistical analysis. Results:(1)One hundred and fourteen cases were diagnosed with malignant tumor and 12 with benign. The sensitivity, specificity, positive predictive value and negative predictive value of ^18F-FDG PET/CT were 37.72%, 83.33%, 95.56% and 12.35% respectively.(2)The size and SUV of primary tumors in 16 cases with metastasis increased significantly to those without metastasis(Z=-4.12, Z=-4.26, P〈0.001).(3)The size, SUV of primary tumors and incidence of metastasis of 41 old patients against middle-age group have not statistic significance.(4)The SUV of primary clear-cell carcinoma were decreased significantly than other pathological subtype of parenchyma neoplasm. No difference was found between clear cell carcinoma and other malignant tumor. Conclusion: SUVmax and T/B ratio are not suitable to renal parenchyma carcinoma diagnosis. Hyper-metabolism in primary tumor can guarantee malignant recognition and give clue for pathological type. With the increase of the primary tumor size and metabolism, the incidence of metastasis raise. These results provide probability that ^18F-FDG-PET can be used as prognosis method for this malignant group. The approaches of this study can be applied to middle age population with suspicious for renal parenchyma tumor.
出处 《中国医学装备》 2016年第3期46-50,共5页 China Medical Equipment
基金 国家自然科学基金(81071188)"用于原发性肝癌早期诊断和疗效监测的PET/CT动态图像采集及处理模式研究" 国家自然科学基金(81571713)"肝细胞癌乙酸盐PET动态显像的动力学分析及临床应用研究" 北京市科学技术委员会资助项目(Z151100003915133)"利用11C-Acetate和18F-FDG PET/CT联合显像评估多发性骨髓瘤治疗疗效及预后"
关键词 肾实质来源肿瘤 氟18-氟代脱氧葡萄糖 正电子发射计算机断层显像 Renal parenchyma neoplasm ^18F-flurodeoxyglucose Positron emission tomography
  • 相关文献

参考文献12

  • 1Nigel C,Damian C,Confield S,et al. EAU Guidelines on Renal Cell Carcinoma:The 2010 U Ixtate[J]. EuropeanU rology, 2010, 58(3)= 398-406.
  • 2Federica M,Francew~ B,Bosio G,et al.Role of F18- FDG-PET/CT in restaging patient.s affected by renal carcinoma[J].Nuclear Meal Rev,2013,16(1):3-8.
  • 3Chen JL,James L,Daniel E,et al. FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer[J]. Cancer Medicine, 2013,2(4): 545-552.
  • 4霍力,周前,吴战宏,肖河,卢朝辉,李汉忠.^(11)C-乙酸盐PET显像在肾脏肿瘤诊断中的作用[J].中华核医学杂志,2006,26(4):205-208. 被引量:20
  • 5Bird VG,Kanagarajah P,Morillo G,et al. Differentiation of oncocytoma and renal cell carcinoma in small renal masses(<4cm):the role of 4-phase computerized tomography[J].World J Urol, 2011,29(6): 787-792.
  • 6Young JR,Margolls D,Sauk S,et al.Clear cell renal cell careinoma:discmnination from other renal cell carcinoma subt~ and oncocytoma at multiphasic multidetector CT[J]. Radiology, 2013,267(2) :444-453.
  • 7Shakher R,Gwynne W,Bolton DM,et al. Clinical role of F-18fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma[Jl.J Urol, 2001,166(3):825-830.
  • 8Kang DE,White RL,Zuger JH,et al. Clinical use of 18F-fluorodeoxyglucose positron emission tomography for detection of renal cell carcinoma[J]. J U rol, 2004, 171 (5): 1806-1809.
  • 9Ozulker T,Ozbek E,Oapacaci T,et al.A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/ computed tomography in the evaluation of indeterminate renal masses[J].Nucl Med Commum, 2011,32(4): 265-272.
  • 10Aysel S,Ahmet A,Silva FB,et al.Associations between the standardized uptake of 18F-FDGPET/CT and demographic,clinical, pathological, radiological factors in lung cancer[J].Int J Exp Med,2015,8(9). 15794-15800.

二级参考文献6

  • 1丁小强.肾脏肿瘤.见:陈灏珠,主编.实用内科学(下册).第8版.北京:人民卫生出版社,2003.2075-2086.
  • 2Liu RS,Hsich HJ,Guo WY,et al.Positron emission tomography with 1-^18C-acetate in meningiomas.J Nucl Med,2004,45:265.
  • 3Ho CL,Yu SCH,Yeung DWC.^11C-acetate PET imaging in bepatocellular carcinoma and other live masses.J Nucl Med,2003,44:213-221.
  • 4Fricke E,Machtens S.HoF-Fmann M,et al.Positron emission tamography with ^11C-acatate and ^18F-FDG in prostate cancer patients.Eur J Nucl Med Mol Imaging,2003,30:607-611.
  • 5Shreve P,Cluao PC,Humes HD,et al.^11C-acetate PET imaging in renal disense.J Nucl Med,1995,36:1595-1601.
  • 6Ho CL,Cheng TKC,Yeun DWC,et al.^11C-acetate PET imaging in the dieferentiation of renal angiomyolipoma and renal cell caremoma.J Nucl Med,2005,46:103.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部